ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 149 filers reported holding ATARA BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,480,000 | -8.1% | 1,000,000 | 0.0% | 7.58% | -33.6% |
Q2 2023 | $1,610,000 | -44.5% | 1,000,000 | 0.0% | 11.42% | -36.4% |
Q1 2023 | $2,900,000 | -11.6% | 1,000,000 | 0.0% | 17.94% | +63.8% |
Q4 2022 | $3,280,000 | -13.2% | 1,000,000 | 0.0% | 10.95% | +13.2% |
Q3 2022 | $3,780,000 | -51.5% | 1,000,000 | 0.0% | 9.67% | -23.8% |
Q2 2022 | $7,790,000 | -16.1% | 1,000,000 | 0.0% | 12.69% | +88.6% |
Q1 2022 | $9,290,000 | -41.1% | 1,000,000 | 0.0% | 6.73% | +4.0% |
Q4 2021 | $15,760,000 | -16.1% | 1,000,000 | -4.8% | 6.47% | +21.6% |
Q3 2021 | $18,795,000 | +20.9% | 1,050,000 | +5.0% | 5.32% | +24.3% |
Q2 2021 | $15,550,000 | +8.3% | 1,000,000 | 0.0% | 4.28% | -3.5% |
Q1 2021 | $14,360,000 | -26.8% | 1,000,000 | 0.0% | 4.44% | -19.5% |
Q4 2020 | $19,630,000 | +51.5% | 1,000,000 | 0.0% | 5.51% | +16.3% |
Q3 2020 | $12,960,000 | +11.2% | 1,000,000 | +25.0% | 4.74% | -11.9% |
Q2 2020 | $11,656,000 | +519.7% | 800,000 | +262.0% | 5.38% | +210.0% |
Q1 2020 | $1,881,000 | – | 221,000 | – | 1.74% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KPCB XV Associates, LLC | 1,876,650 | $29,182,000 | 13.03% |
Copernicus Capital Management, LLC | 50,000 | $778,000 | 12.27% |
Antipodean Advisors LLC | 1,000,000 | $15,550,000 | 4.28% |
BRIDGER MANAGEMENT, LLC | 1,325,188 | $20,607,000 | 1.92% |
Redmile Group, LLC | 6,449,577 | $100,291,000 | 1.48% |
MAVERICK CAPITAL LTD | 7,704,676 | $119,808,000 | 1.12% |
Baupost Group | 8,477,488 | $131,825,000 | 1.07% |
ACT CAPITAL MANAGEMENT, LLC | 116,900 | $1,818,000 | 0.93% |
Trellus Management Company, LLC | 73,056 | $1,136,000 | 0.78% |
PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $8,164,000 | 0.75% |